Also Known As: Idamycin PFS, Idarubicin Hydrochloride
4-Demethoxydaunorubicin, also called Idamycin PFS or idarubicin hydrochloride, is a chemotherapy drug used with other medicines to treat adults with acute myeloid leukemia (AML). It works by blocking enzymes cancer cells need to divide and repair DNA, which may help kill these cells. It belongs to a group of drugs called anthracycline antibiotics and topoisomerase inhibitors.
Also Known As: 4-Nitroquinoline 1-Oxide
4-NQO, or 4-Nitroquinoline 1-Oxide, is a chemical used in cancer research to cause tumors in laboratory animals. Scientists use it to study how cancer develops and to test new treatments or prevention methods. It is not a medicine or treatment for people but a research tool that helps improve cancer care.
Also Known As: 45 Code Of Federal Regulations Part 46, Human Participant Protection Regulations, And Protection Of Human Subjects
45 CFR 46 is a set of U.S. federal rules that protect people who take part in research studies. These regulations ensure that research involving human participants is done safely and ethically, especially when a federal agency is involved. They require clear explanations, informed consent, and ongoing safety monitoring to respect and safeguard participants’ rights and well-being.
Also Known As: 45 CFR 46, Human Participant Protection Regulations, And Protection Of Human Subjects
45 Code of Federal Regulations Part 46 (45 CFR 46) is a set of U.S. federal rules that protect people who take part in research studies. These laws ensure that research involving human participants is done safely and ethically, especially when federal agencies are involved. They require clear explanations, informed consent, and ongoing safety monitoring to respect and safeguard participants’ rights and well-being.